Endometrial cancer, also known as uterine cancer, arises from the inner lining of the uterus and is most common in women over 50. It is often detected early due to symptoms like abnormal bleeding, leading to high survival rates with timely treatment. India offers advanced gynecologic oncology care at a fraction of Western costs. Endometrial cancer treatment in India ranges between $3,500 and $8,500, including surgery, radiation, and medication, depending on the stage and hospital choice.
Endometrial cancer is a malignancy that originates in the endometrium, the inner lining of the uterus. It is the most common gynecologic cancer in developed and developing countries. Most cases are diagnosed early due to postmenopausal bleeding, which leads women to seek medical attention.
Unlike uterine sarcomas (which affect the muscle layer), endometrial cancer affects only the lining of the uterus. It differs from cervical cancer, which arises in the cervix, and has different causes, symptoms, and treatment protocols. Endometrial cancer is usually hormone-sensitive and grows slowly, making early treatment highly effective.
Type 1 (Endometrioid Adenocarcinoma)
Type 2 (Serous or Clear Cell Carcinoma):
Grade 1: Well-differentiated, slow-growing
Grade 2: Moderately aggressive
Grade 3: Poorly differentiated, high-grade tumors
Several factors contribute to the development of endometrial cancer:
Symptoms usually present early and include:
These symptoms should prompt immediate evaluation.
How Is Endometrial Cancer Diagnosed?
Diagnosis is a multi-step process that includes:
The FIGO staging system (I–IV) is used:
Stage I: Confined to the uterus
Stage II: Spread to cervix
Stage III: Spread to pelvic tissues or lymph nodes
Stage IV: Spread to bladder, bowel, or distant organs
Staging helps determine the treatment approach and prognosis.
When detected in Stage I, the 5-year survival rate is over 95%. Early treatment:
India offers:
Dr. Ankur Bahl is one of India’s leading oncologists, known for:
Treatment Component |
Estimated Cost (USD) |
Diagnostic Workup (Imaging, Biopsy) |
$300 – $700 |
Hysterectomy Surgery |
$2,000 – $4,500 |
Radiation Therapy (Complete) |
$2,000 – $3,500 |
Chemotherapy (Per Cycle) |
$300 – $600 |
Hormonal Therapy (per year) |
$500 – $1,000 |
Total Treatment Cost |
$3,500 – $8,500 |
India’s prices are significantly lower than the US/UK, where similar treatment may cost $25,000 to $50,000+.
Post-treatment, patients require regular monitoring to ensure recurrence is not occurring:
Regular follow-up and lifestyle modifications help extend long-term survival.
Endometrial cancer, when detected early, is highly treatable with excellent survival rates. India offers high-quality, affordable care, especially for international patients seeking timely intervention. With expert oncologists like Dr. Ankur Bahl and advanced medical infrastructure, patients receive comprehensive, compassionate, and effective treatment tailored to their needs.
Contact today for a consultation, cost estimate, or a second opinion for uterine cancer care in India.
Yes. When diagnosed in Stage I, endometrial cancer has an excellent prognosis. Many women are completely cured with surgery alone, and the 5-year survival rate exceeds 95%. Early intervention offers the best outcomes with fewer complications.
Not all patients require chemotherapy or radiation. If the cancer is low-grade and confined to the uterus, surgery may be sufficient. However, if the disease has spread to lymph nodes or is high-grade, your oncologist may recommend additional therapy for better long-term control.
In very early-stage, low-grade cases (especially in younger women), fertility-preserving treatment may be an option using hormonal therapy and regular monitoring instead of immediate surgery. This is only advised after a detailed risk-benefit discussion with your oncologist and fertility specialist.
Most patients undergoing a minimally invasive hysterectomy can return home within 3–5 days. Recovery usually takes 2–4 weeks. You may experience mild discomfort, fatigue, or hormonal changes, but modern pain management and support make recovery smooth and manageable.
Absolutely. India is home to internationally accredited hospitals with board-certified oncologists and surgeons. Facilities are equipped with the latest medical technologies and offer comprehensive support for international patients, including visa help, accommodation, and post-treatment follow-up.
Yes, in some early-stage or hormone-sensitive cases, especially when surgery is not suitable due to age or health conditions. Hormonal medications such as progestins can help control cancer growth. However, this approach requires careful monitoring and is not suitable for all patients.
Yes. Regular follow-up is critical to ensure that the cancer has not returned. This includes pelvic exams every 3–6 months, imaging if needed, and managing any side effects from treatment. Emotional support, nutrition counseling, and hormone replacement (if required) are also part of survivorship care.